PT1018341E - Agentes anti-stress e alimentos funcionais - Google Patents

Agentes anti-stress e alimentos funcionais

Info

Publication number
PT1018341E
PT1018341E PT98901519T PT98901519T PT1018341E PT 1018341 E PT1018341 E PT 1018341E PT 98901519 T PT98901519 T PT 98901519T PT 98901519 T PT98901519 T PT 98901519T PT 1018341 E PT1018341 E PT 1018341E
Authority
PT
Portugal
Prior art keywords
pro
functional foods
agents
stress agents
antistress
Prior art date
Application number
PT98901519T
Other languages
English (en)
Inventor
Akihiro Masuyama
Toshiaki Takano
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Publication of PT1018341E publication Critical patent/PT1018341E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Confectionery (AREA)
PT98901519T 1997-09-26 1998-02-05 Agentes anti-stress e alimentos funcionais PT1018341E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26242297A JP4727770B2 (ja) 1997-09-26 1997-09-26 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤

Publications (1)

Publication Number Publication Date
PT1018341E true PT1018341E (pt) 2004-08-31

Family

ID=17375571

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98901519T PT1018341E (pt) 1997-09-26 1998-02-05 Agentes anti-stress e alimentos funcionais

Country Status (23)

Country Link
US (1) US6410685B1 (pt)
EP (1) EP1018341B1 (pt)
JP (1) JP4727770B2 (pt)
KR (2) KR100379819B1 (pt)
CN (1) CN1198641C (pt)
AT (1) ATE264687T1 (pt)
AU (1) AU728565B2 (pt)
BG (1) BG64692B1 (pt)
BR (1) BR9813222A (pt)
CA (1) CA2303810C (pt)
CZ (1) CZ298848B6 (pt)
DE (1) DE69823369T2 (pt)
DK (1) DK1018341T3 (pt)
ES (1) ES2219868T3 (pt)
HU (1) HUP0004617A3 (pt)
ID (1) ID25635A (pt)
IN (1) IN190794B (pt)
PL (1) PL192873B1 (pt)
PT (1) PT1018341E (pt)
SK (1) SK285148B6 (pt)
TR (1) TR200000863T2 (pt)
TW (1) TWI231213B (pt)
WO (1) WO1999016461A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334627A (en) * 1999-03-12 2002-07-26 Horticulture & Food Res Inst A therapeutic composition containing a therapeutic agent such as an anthelmintic and an antistress agent such as metyrapone or a nitric oxide promoter for increasing efficacy of therapeutic agents and animal growth
FR2793257B1 (fr) 1999-05-06 2001-07-27 Gervais Danone Sa Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
JP4633876B2 (ja) * 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
DE10105040A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105041A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
DE10105038B4 (de) 2001-02-05 2005-07-07 Neurotell Ag Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
EP1509609B1 (en) 2002-06-04 2015-04-22 DSM IP Assets B.V. Protein hydrolysate rich in tripeptides
EP1550443A4 (en) * 2002-09-18 2009-04-01 Ajinomoto Kk COMPOSITION AGAINST STRESS-BASED DISEASES
US20050222263A1 (en) * 2002-09-18 2005-10-06 Ajinomoto Co., Inc. Compositions against stress-related diseases and methods for treating stress-related diseases
TWI344371B (en) * 2003-03-18 2011-07-01 Suntory Holdings Ltd Angiotensin-converting enzyme inhibitory peptides
JP2006525003A (ja) * 2003-05-05 2006-11-09 ユニリーバー・ナームローゼ・ベンノートシヤープ Ｉｐｐおよび／またはｖｐｐを含む加水分解カゼイン製品
JP2007529206A (ja) * 2004-03-19 2007-10-25 カンピーナ ネーダーランド ホールディング ビー．ブイ． アンジオテンシン−ｉ−変換酵素阻害特性を有する食品成分及び食品の調製方法、並びにその方法により得られる製品
BRPI0513237A (pt) * 2004-07-12 2008-04-29 Dsm Assets B V hidrolisados de proteìna para diminuição de pressão sanguìnea
WO2006089921A1 (en) * 2005-02-24 2006-08-31 Dsm Ip Assets B.V. Blood pressure lowering peptides from glycomacropeptide
BRPI0613979A2 (pt) * 2005-07-26 2011-02-22 Calpis Co Ltd processo para a produção de leite fermentado e bebida/alimento feito a partir de leite fermentado
US20100166859A1 (en) * 2006-01-16 2010-07-01 Luppo Edens Novel nutraceutical compositions and use thereof
US20090111758A1 (en) * 2006-05-15 2009-04-30 Valio Ltd. Use of therapeutically useful peptides
JP5394628B2 (ja) * 2007-02-09 2014-01-22 クロスフィールドバイオ株式会社 新規なラクトバチルス属微生物および乳酸菌製剤
WO2009062914A2 (en) * 2007-11-14 2009-05-22 Dsm Ip Assets B.V. Novel blood pressure lowering composition
JP5618395B2 (ja) * 2009-08-13 2014-11-05 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
JP2011136932A (ja) 2009-12-28 2011-07-14 Calpis Co Ltd 脳機能改善用組成物および脳機能を改善する方法
JP2010183918A (ja) * 2010-06-01 2010-08-26 Calpis Co Ltd トリペプチドの製造方法
CN102399261B (zh) * 2010-09-07 2014-06-25 任发政 具有血管紧张素转化酶c-端选择性抑制活性的三肽及其应用和组合物
JP2011102331A (ja) * 2011-02-17 2011-05-26 Calpis Co Ltd 尿中ドーパミン低下の予防及び軽減剤
JP5892687B2 (ja) 2011-07-07 2016-03-23 高砂香料工業株式会社 風味改善ペプチド
CN103204909B (zh) * 2013-04-17 2014-09-03 苏州凯祥生物科技有限公司 一种抗高血压活性肽vppipp
JP5853326B2 (ja) * 2013-12-24 2016-02-09 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
JP2014208702A (ja) * 2014-07-31 2014-11-06 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
CN104725485B (zh) * 2014-11-19 2018-01-16 扬州大学 一种重组活性肽及其同步制备方法
JPWO2017057319A1 (ja) * 2015-09-30 2018-07-19 株式会社明治 乳酸菌スターターの調製方法及び発酵乳の製造方法
CN111909978B (zh) * 2020-07-10 2021-06-22 青岛农业大学 一种利用发酵法从玉米蛋白粉中定向制备富含lpp水解物的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189064A (en) * 1985-07-22 1993-02-23 Matrix Technologies, Inc. Treatment of ***e addiction
GB2227658A (en) * 1989-02-03 1990-08-08 Cellana Thyrotropin releasing hormone (trh) composition for enhancing immune function
KR900012945A (ko) * 1989-02-16 1990-09-03 가와무라 요시부미 렌닌 억제활성을 갖는 펩타이트, 그 제조방법 및 용도
US5593967A (en) * 1990-08-31 1997-01-14 Warner-Lambert Company Cholecystokinin antagonists, their preparation and therapeutic use
US5264419A (en) * 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives
JP2904655B2 (ja) * 1992-09-17 1999-06-14 サントリー株式会社 抗ストレス剤
US5639729A (en) * 1993-08-26 1997-06-17 Immunobiology Research Institute, Inc. Tripeptides useful in immune and CNS therapy
US5604198A (en) * 1994-05-12 1997-02-18 Poduslo; Joseph F. Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents
JPH08275752A (ja) * 1995-04-07 1996-10-22 Riken Vitamin Co Ltd ストレス改善食品
JPH0920660A (ja) * 1995-07-04 1997-01-21 Suntory Ltd 抗ストレス組成物
JP4065038B2 (ja) * 1996-08-07 2008-03-19 カルピス株式会社 計算作業負荷ストレス緩和剤

Also Published As

Publication number Publication date
JPH11100328A (ja) 1999-04-13
PL192873B1 (pl) 2006-12-29
WO1999016461A1 (fr) 1999-04-08
AU728565B2 (en) 2001-01-11
BG64692B1 (bg) 2005-12-30
SK4362000A3 (en) 2001-03-12
HUP0004617A3 (en) 2001-11-28
BR9813222A (pt) 2000-08-29
CA2303810A1 (en) 1999-04-08
HUP0004617A2 (hu) 2001-05-28
IN190794B (pt) 2003-08-23
EP1018341A4 (en) 2002-08-28
SK285148B6 (sk) 2006-07-07
TR200000863T2 (tr) 2000-11-21
CZ20001083A3 (cs) 2001-01-17
ES2219868T3 (es) 2004-12-01
DE69823369D1 (de) 2004-05-27
CN1279614A (zh) 2001-01-10
ID25635A (id) 2000-10-19
AU5780198A (en) 1999-04-23
JP4727770B2 (ja) 2011-07-20
KR20010024277A (ko) 2001-03-26
KR20030005137A (ko) 2003-01-15
DE69823369T2 (de) 2005-05-04
EP1018341B1 (en) 2004-04-21
KR100383492B1 (ko) 2003-05-12
DK1018341T3 (da) 2004-07-26
PL339348A1 (en) 2000-12-18
ATE264687T1 (de) 2004-05-15
KR100379819B1 (ko) 2003-04-14
US6410685B1 (en) 2002-06-25
EP1018341A1 (en) 2000-07-12
CZ298848B6 (cs) 2008-02-27
BG104381A (en) 2001-02-28
TWI231213B (en) 2005-04-21
CA2303810C (en) 2007-03-27
CN1198641C (zh) 2005-04-27

Similar Documents

Publication Publication Date Title
PT1018341E (pt) Agentes anti-stress e alimentos funcionais
CA2223510A1 (en) Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
EP0966969A4 (en) ANTI-STRESS ACTIVE AND FUNCTIONAL NUTRIENTS WITH ANTI-STRESS EFFECTS
WO2003051313A3 (en) Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes
DE60119784D1 (de) Cyclische salen metall verbindungen als einfänger von sauerstoffradikalen und verwendbar als antioxidantien bei der behandlung und vorbeugung von krankheiten
ES2194720T3 (es) Enzimas para el tratamiento de diabetes mellitus tipo i.
ES2095926T5 (es) Cyclosporins.
IT1312377B1 (it) Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche
GB2288732B (en) Pharmaceutical compositions
WO2003013549A3 (de) Formulierung enthaltend (lyso-) phosphatidylserin zur vorbeugung und behandlung von stresszuständen bei warmblütern
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
ATE252389T1 (de) Ein arzneimittel zur behandlung von fettleibigkeit und verbesserung des lipidmetabolismus
NO20006646L (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
DE60023657D1 (de) Inhibitore der verzweigte-aminosäure-abhängigen aminotransferase und deren verwendung in der behandlung der zuckerkranke retinopathie
TW200637542A (en) Lipase inhibitor, preventing and treating agent of skin disease
NO870584L (no) Mikrobicider.
EP1690869A4 (en) A PEPTIDE INHIBITING ANGIONTENSIN CONVERTING ENZYME
NO20001196L (no) Nootropisk middel
DE69902879D1 (de) Pflanzliches antivirales mittel
WO1997005864A3 (en) Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
WO2000059531A3 (en) Therapeutic uses of bpi protein products in bpi-deficient humans
TH42734A (th) สารต้านความเครียดและอาหารที่ทำหน้าที่
PL367613A1 (en) Composition for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder
Park Inhibition of Korean radish peroxidase by sodium azide
DE69626307D1 (de) Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes